E Fund Management Co., Ltd. Catalyst Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.8 Billion
- Q2 2024
A detailed history of E Fund Management Co., Ltd. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 11,266 shares of CPRX stock, worth $225,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,266
Previous 23,003
51.02%
Holding current value
$225,320
Previous $366,000
52.46%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CPRX
# of Institutions
285Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$374 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$183 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$121 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$60 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.06B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...